Related Experiment Video
Updated: Jul 8, 2026
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent
Valentina A Schmidt1, Carmine S Chiariello, Encarnación Capilla
1Division of Hematology, HSC T15, Rm 040, State University of New York at Stony Brook, Stony Brook, NY 11794-8151, USA. vaschmidt@notes.cc.sunysb.edu
Abstract:
IQGAPs are multidomain scaffolding proteins that integrate Rho GTPase and Ca2+/calmodulin signals with cell adhesive and cytoskeletal reorganizational events. Targeted disruption of the murine Iqgap2 gene resulted in the age-dependent development of apoptosis and hepatocellular carcinoma (HCC), characterized by the overexpression of IQGAP1, the loss of membrane E-cadherin expression, the cytoplasmic translocation (and activation) of beta-catenin, and the overexpression of a nuclear target of beta-catenin, cyclin D1. In normal hepatocytes, IQGAP2 was found to exist as one component of a multifunctional scaffolding complex comprising IQGAP1, beta-catenin, and E-cadherin, with no evidence for direct IQGAP1-IQGAP2 interactions. Interbreeding of Iqgap2(-/-) mice into the Iqgap1(-/-) background resulted in the phenotypic correction of the preexisting hepatopathy, decreases in the incidence and sizes of HCC tumors, and the normalization of overall survival rates compared to those of Iqgap2(-/-) mice, suggesting that maximal penetrance of the Iqgap2(-/-) HCC phenotype requires the coordinate expression of IQGAP1. These results identify Iqgap2 as a novel tumor suppressor gene specifically linked to the development of HCC and the activation of the Wnt/beta-catenin signaling pathway, while also suggesting that IQGAP1 and IQGAP2 retain functionally divergent roles in hepatocellular carcinogenesis.
Insights
Loss of Iqgap2 in mice promotes liver cancer (HCC) by activating beta-catenin signaling. Co-expression of IQGAP1 is required for this HCC development, indicating Iqgap2 is a tumor suppressor.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- IQGAP proteins are scaffolds integrating signaling pathways with cellular organization.
- Dysregulation of IQGAP proteins is implicated in various cancers.
Purpose of the Study:
- To investigate the role of Iqgap2 in hepatocellular carcinoma (HCC) development.
- To elucidate the relationship between IQGAP1 and IQGAP2 in liver carcinogenesis.
Main Methods:
- Gene targeting to disrupt the murine Iqgap2 gene.
- Analysis of HCC development, protein expression, and signaling pathways in knockout mice.
- Cross-breeding experiments between Iqgap2(-/-) and Iqgap1(-/-) mice.
Main Results:
- Iqgap2 deficiency led to age-dependent HCC, characterized by IQGAP1 overexpression, loss of E-cadherin, beta-catenin activation, and cyclin D1 upregulation.
- IQGAP2 interacts with IQGAP1, beta-catenin, and E-cadherin in normal hepatocytes.
- Eliminating IQGAP1 in Iqgap2(-/-) mice corrected the liver phenotype and reduced HCC incidence, demonstrating IQGAP1's necessity for HCC development.
Conclusions:
- Iqgap2 acts as a tumor suppressor gene in the liver, specifically linked to HCC development.
- The HCC phenotype in Iqgap2(-/-) mice is dependent on the presence of IQGAP1.
- IQGAP1 and IQGAP2 play distinct roles in hepatocellular carcinogenesis and Wnt/beta-catenin pathway regulation.
